🤖 How is #AI transforming evidence in modern cardiovascular research?
Join our #EvidenceLab webinar on "AI-Augmented Clinical Trials: Smarter, Faster, Better"
🎙️@fwasselbergs and @Costa_F_8
📅 Tue, March 17
⏰ 17:00
Register here 👉 https://t.co/Dms99gklX8
Don’t miss the next session of our EvidenceLab: Turning data into decisions webinar series, led by Dr. @CaoDavide and Dr. Francesco Costa. Join us for Building successful clinical trials: From concept to execution, Tuesday, Feb 17, 17–18:30. Register now: https://t.co/1yfTGr7Mjn
Join EvidenceLab: Turning data into decisions webinar series designed for cardiovascular professionals in Feb - Mar 2026. Led by Dr. @CaoDavide this webinar series brings together leading experts to explore the methodology behind clinical trials: https://t.co/VNR3qLykfU
What a great first-time experience at #LondonValves 2024! Big shoutout to #PCR for the fantastic program and organization (I forgive you for uploading my slides to the wrong session). Definitely becoming a regular attendee of this course. #PCRLV@PCRonline
Kicked off #TCT with an incredible first LBT session, diving into the latest data on early intervention for aortic stenosis. @TCTConference@TCTMD@crfheart
Don’t miss tomorrow’s #CardioStories with Prof. @EmanueleBarba13 on the pitfalls and biases of RCTs. #webinar
🗓️ 4th September at 17:00 CEST
👉 Free registration — link in the comments
Randomized trials are the gold standard in clinical research, providing the strongest evidence for treatment effectiveness. However, they come with their own challenges and limitations
Join @EmanueleBarba13 & me on Sept 4th as we discuss pitfalls and biases of RCTs
👉Link below
Randomized trials are the gold standard in clinical research, providing the strongest evidence for treatment effectiveness. However, they come with their own challenges and limitations
Join @EmanueleBarba13 & me on Sept 4th as we discuss pitfalls and biases of RCTs
👉Link below
ACS presentations often limit the use of short DAPT after PCI, even among HBR patients. Our new study shows 1-month DAPT after NSTE-ACS is safe and reduces bleeding—though there are some caveats!
👉 Learn more in @EuroInterventio
https://t.co/VY8sdexo9n
#EuroPCR - Behind the scenes! 🎥
Live case from @ICPS on LM & complex bifurcation PCI with @DrThomasHovasse & @HakimBenamer
H 13:30 Theatre Bleu
See you soon
@johnwmcevoy@DFCapodanno Would a non-inferiority trial (and its arbitrary margin) be more persuasive? In this scenario, the upper 95% CI for HR of the non-BB group would have been 1.27
#ACC24 Round Up: Ten Original Articles were simultaneously published in NEJM and presented at this year’s American College of Cardiology Scientific Sessions in Atlanta. View the full thread for all @ACCinTouch articles and bookmark this post for future reference.